Life ScienceCompany
Questcor Pharmaceuticals M&A Summary
Questcor Pharmaceuticals has acquired 3 companies of its own. It has also divested 1 asset.
Questcor Pharmaceuticals’ largest acquisition to date was in 2013, when it acquired Rights to Synacthen for $60M. It’s largest disclosed sale occurred in 2019, when it sold BioVectra to H.I.G. Private Equity for $250M. Questcor Pharmaceuticals has acquired in 1 US state, and 2 countries. The Company’s most targeted sectors include life science (67%) and healthcare services (34%).
Questcor Pharmaceuticals Ownership
Who owns Questcor Pharmaceuticals?
Questcor Pharmaceuticals is owned by Mallinckrodt. It was acquired on August 14, 2014.
Was Questcor Pharmaceuticals formerly PE-backed?
Yes. Questcor Pharmaceuticals was formerly owned by 1 private investor.
Questcor Pharmaceuticals Business Overview
Where is Questcor Pharmaceuticals headquartered?
Questcor Pharmaceuticals is headquartered in Anaheim, California.
What sector is Questcor Pharmaceuticals in?
Questcor Pharmaceuticals is a life science company.
When was Questcor Pharmaceuticals founded?
Questcor Pharmaceuticals was founded in 1990.
M&A Summary
-
M&A Total Activity4
- M&A Buy Activity3
- M&A Sell Activity1
- Total Sectors Invested 2
- Total Countries Invested 2
- M&A Buy/Sell Connections 3
- M&A Advisors 1
Unlimited Searches
